Form D · Pharmaceuticals
Pelthos Therapeutics Inc.
Durham, NC · CIK 0001919246
Offering snapshot reported Nov 16, 2026 · SEC filing
- Reported sold
- $57.5M Offering amount: $57.5M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 30, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 16, 2026 | Initial | $57,500,000 | No comparison | 7 | SEC filing |
| Nov 19, 2025 | Initial | $18,000,000 | No comparison | 8 | SEC filing |
| Jul 10, 2025 | Initial | $50,100,000 | No comparison | 13 | SEC filing |
| Aug 6, 2024 | Initial | $750,000 | No comparison | 1 | SEC filing |
| Aug 6, 2024 | Initial | Yet to sell | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-604899
Source: Form D, filed Nov 16, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Baxter | Director |
| Todd Davis | Director |
| Andrew Einhorn | Director |
| Ezra Friedberg | Director |
| John M. Gay | Executive |
| Peter Greenleaf | Director, Executive |
| Francis Knuettel | Executive |
| Francis Knuettel Ii | Executive |
| Eric Lang | Executive |
| Richard Malamut | Director |
| Matthew Pauls | Director |
| Scott Plesha | Director, Executive |
| Sai Rangarao | Executive |
| Chia Lin Simmons | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4020 Stirrup Creek Drive, Suite 110
Durham, NC, 27703
Durham, NC, 27703